4D Molecular Therapeutics Overview
4D Molecular Therapeutics Target Price
Analysts' 12-month price predictions for FDMT.
Share Price
$3.24
Average Target Price
$6.00
85.2% upside
85.2% upside1 analysts in the last 4 months
High: $6 | Low: $6
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-01-11 | Morgan StanleyJudah Frommer | $6 | 85.2% upside |  |
| 2024-09-19 | BMO CapitalKostas Biliouris | $40 | 1134.6% upside | |
| 2024-09-19 | Loop Capital MarketsGeulah Livshits | $39 | 1103.7% upside | |
| 2024-09-19 | H.C. WainwrightMatthew Caufield | $36 | 1011.1% upside | |
| 2024-04-15 | RBC CapitalLisa Walter | $40 | 1134.6% upside | |
| 2024-04-15 | BarclaysGena Wang | $45 | 1288.9% upside | |
| 2024-04-01 | JefferiesNalin Tejavibulya | $58 | 1690.1% upside | |
| 2024-03-28 | BMO CapitalKostas Biliouris | $63 | 1844.4% upside | |
| 2024-02-06 | BMO CapitalKostas Biliouris | $70 | 2060.5% upside | |
| 2023-07-05 | Chardan CapitalGeulah Livshits | $30 | 825.9% upside | |
| 2022-11-18 | H.C. Wainwright | $36 | 1011.1% upside | |
| 2022-04-05 | Evercore ISIJosh Schimmer | $40 | 1134.6% upside | |